(Formerly known as Central Clinical School)
 |
| Dr Emma Foster has been awarded a Viertel Clinical Investigator Award |
 |
| L-R: Dr Michael Zhong, Ms Maria (Pia) Campagna and Dr Vilija Jokubaitis have won an MS Australia incubator grant |
From their MS Australia project description, they write:
 |
| Rats' spacial cognition is not affected by a high sugar diet: Study |
 |
| L-R: Dr Hugh Simpson (first author), Professor Patrick Kwan (senior author) and Dr Ben Chen (co-corresponding author) on a paper modelling the probability of a person with epilepsy achieving future freedom from seizure. Study |
Epilepsy is a neurological disorder characterised by seizures that are caused by a disruption of electrical activity in the brain. Over 14,000 new cases of epilepsy were reported between 2019 – 2020. Epilepsy is the second most burdensome neurological condition after dementia and costs the Australian economy $12.3 billion per annum. People with epilepsy often experience depression, anxiety, suicide, migraine or stroke at significantly higher rates than that of the general population.
No cure exists for epilepsy. However, medication-based treatment to control seizures is relatively effective in approximately 70% of patients. The focus of treatment is to both achieve and maintain ‘seizure freedom’ for patients in order to reduce associated health complications, and maximise quality of life and productivity.
A study published recently in the influential neuroscience journal, Brain, led by senior author Professor Patrick Kwan, has developed and validated models capable of predicting the probability that a person with epilepsy will achieve future seizure-freedom. These models may be used to inform treatment decision making.
 |
| The Monash led ENIGMA-Ataxia working group is collecting and analysing data worldwide on Friedreich Ataxia |
Friedreich Ataxia (FRDA) is a rare inherited disease affecting between 500-800 Australians. It is a neurological disorder causing damage in areas of the nervous system responsible for movement and sensation. It shows initially with abnormal, uncoordinated movements, and over time as the disease progresses, a whole constellation of problems emerges.
Early diagnosis can help with managing the symptoms, allowing improved quality of life for people with the illness, but there is no cure.
 |
| A cortical neuron stained green with antibody to Neurofilament light (NfL). CCS neuroscience researchers are investigating NfL as a biomarker for traumatic brain injury & peripheral injuries: study. Image: Wikimedia. |
 |
| L-R: Professor Natasha Lannin has been nominated a global leader in Rehabilitation Therapy, Professor Paul Myles a top researcher in the field of Anesthesiology and Emeritus Professor Jeffrey Rosenfeld in Neurosurgery in The Australian's RESEARCH 2021 List. |
The Australian’s Research magazine takes a deep dive into Australian research, revealing its excellence in The List (published November 10, 2021). Congratulations to our researchers - see detail below.
The authors, Tim Dodd and Paul McCarthy, write, "Not for many decades has the value of research been so clear. Less than two years after the appearance of a new and dangerous virus, and thanks to countless researchers in infectious disease, immunology, epidemiology and other fields, we now have many effective vaccines in mass production, and numerous tests and treatments for Covid-19.
"In The Australian’s annual Research magazine, we acknowledge the talent and dedication of our researchers. And again, as we have for the previous four years, we present The List – a roll call of the best researchers and the best research institutions in Australia in 250 individual fields of research."
